IMRX
US EQUITY
Health Care
Biotechnology & Medical
CIK: 1790340
Immuneering Corp (IMRX) Quant Factor Diagnostic & Fair Value Model
Immuneering Corp (Ticker: IMRX) is listed in the Health Care sector (Biotechnology & Medical). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$3.73
-2.10%
Latest Close (2026-10-23)
Market Cap: $241.32M
P/E Ratio: -
Momentum Strength
3M / 12M
-14.45%
1M: -14.06%
12M: 0.00%
Quality (ROE)
Point-in-Time
-
Trailing Return on Equity
Technical Trend
RSI 14
40.6
SMA50: $4.41
SMA200: $4.51
Valuation Multiplier
Trailing
-
Pre-Profit / Negative TTM
📊
Valuation & Multi-Factor Diagnostic
Pre-Profit / Negative TTM
IMRX has negative or near-zero trailing GAAP earnings over the trailing twelve months.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线整理 (MA20/50)
Piotroski F-Score: 1/9 (Under Pressure or Early Stage Growth)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1790340 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1790340 | ||||||
💡 Methodology & Frequently Asked Questions
Key reference details regarding Immuneering Corp (IMRX) valuation multiples, momentum factors, and point-in-time filing conventions.
How should IMRX's current valuation multiple be interpreted? ↓
IMRX trades at a trailing P/E of -x within the Health Care sector (pre-profit / negative ttm). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are IMRX's key momentum and technical factor indicators? ↓
As of the latest close, IMRX shows a 1-month return of -14.06%, 3-month return of -14.45%, and 12-month return of 0.00%, with a 14-day RSI of 40.6. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for IMRX? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can IMRX be incorporated into systematic factor models? ↓
IMRX can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.